MedPath
TGA Approval

EVEROCAN everolimus 0.75 mg tablet blister pack (335142)

335142

EVEROCAN everolimus 0.75 mg tablet blister pack

Pharmacor Pty Ltd

April 21, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01469-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01468-1

Active Ingredients

everolimus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EVEROCAN everolimus 0.75 mg tablet blister pack (335142) - TGA 批准文号 | MedPath